Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04864925 · ClinicalTrials.gov registry record · Phase 3
Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 46
- Enrollment target
NCT04864925 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 46 participants.
The verdict
NCT04864925, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 46 participants
- Enrollment target
Study Summary
SARS COVID 2 has caused a pandemic of proportions unparalleled in the past 100 years. The virus has an uncanny ability for transmission and as such has been difficult to control. The spread of the virus has affected everything from education, business, politics and survival. While the investigators have learned a great deal in the last 9 months they still face an uncertain day to day existence. Health care workers are particularly vulnerable to transmission of this virus because of their close contact with patients. Moreover, dentists are particularly vulnerable because the virus is spread via aerosols which are generated quite easily in the dental office putting dentists and their associates at risk. The oral cavity appears to be a likely domain for viral carriage particularly since both taste and smell are hallmark effects of the virus. With these issues at hand it will be of great advantage to have a simple routine oral hygiene method in the effort to reduce the oral viral load. There is some reason to expect that oral hygiene procedures with known anti-microbial effects could have some use in our efforts to reduce or control the oral viral load. With this issue in mind investigators feel that stannous fluoride could modify the virus in such a manner as to effectively reduce the oral viral load.
Interventions
- DRUG Colgate Total Clean Mint
- DRUG Tom's Botanically Bright Peppermint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2020-12-28 |
| Est. Completion | 2021-08-25 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04864925
The ClinicalTrials.gov registry entry for NCT04864925 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Colgate Total Clean Mint is the first listed.
NCT04864925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04864925 about?
NCT04864925 is a clinical study titled "Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products". SARS COVID 2 has caused a pandemic of proportions unparalleled in the past 100 years. The virus has an uncanny ability for transmission and as such has been difficult to control. The spread of the virus has affected everything from education, business, politics and survival. While the investigators ...
What is the current status of trial NCT04864925?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 46 participants. The study started on 2020-12-28. Estimated completion is 2021-08-25.
What interventions are being tested in trial NCT04864925?
The interventions under investigation include: Colgate Total Clean Mint (DRUG), Tom's Botanically Bright Peppermint (DRUG).
Who is sponsoring clinical trial NCT04864925?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.